|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | The biology of P-selectin glycoprotein ligand-1:its role as a selectin counterreceptor in leukocyte-endothelial and leukocyte-platelet interaction显示文摘 | YANG J FURIE B C FURIE B | 1999 | Thromb Haemost1999，81，1： | 1 |
| 2 | Declining use of combination infliximab and immunomodulator for inflammatory bowel disease in the community setting显示文摘AIM To describe trends of combination therapy (CT) of infliximab (IFX) and immunomodulator (IMM) for inflammatory bowel disease(IBD) in the community setting. METHODS A retrospective study was conducted of all IBD patients referred for IFX infusion to our community infusion center between 04/01/01 and 12/31/14. CT was defined as use of IFX with either azathioprine, 6-mercaptopurine, or methotrexate. We analyzed trends of CT usage overall, for Crohn's disease (CD) and ulcerative colitis (UC), and for the subgroups of induction patients. We also analyzed the trends of CT use in these groups over the study period, and compared the rates of CT use prior to and after publication of the landmark SONIC trial.RESULTS Of 258 IBD patients identified during the 12 year study period, 60 (23.3%) received CT, including 35 of 133(26.3%) induction patients. Based on the CochranArmitage trend test, we observed decreasing CT use for IBD patients overall(P < 0.0001) and IBD induction patients,(P = 0.0024). Of 154 CD patients, 37(24.68%) had CT, including 20 of 77 (26%) induction patients.The Cochran Armitage test showed a trend towards decreasing CT use for CD overall(P < 0.0001) and CD induction,(P = 0.0024). Overall, 43.8% of CD patients received CT pre-SONIC vs 7.4% post-SONIC (P < 0.0001). For CD induction, 40.0% received CT preSONIC vs 10.8% post-SONIC(P = 0.0035). Among the 93 patients with UC, 19 (20.4%) received CT. Of 50 induction patients, 14 (28.0%) received CT. The trend test of the 49 patients with a known year of induction again failed to demonstrate any significant trends in the use of CT(P = 0.6). CONCLUSION We observed a trend away from CT use in IBD. A disconnect appears to exist between expert opinion and evidence favoring CT with IFX and IMM, and evolving community practice. | Joshua C Berkowitz Joanna Stein-Fishbein Sundas Khan Richard Furie Keith S Sultan | 2018 | World Journal of Gastrointestinal Pharmacology and Therapeutics2018，9，1： | 1 |
| 3 | Trp2313-His2315 of factor Ⅷ C2 domain is involved in membrane binding:structure of a complex between the C2 domain and an inhibitor of membrane binding显示文摘 | Liu Z Lin L Yuan C Nicolaes G A Chen L Meehan E J Furie B Huang M | | 0，，： | 1 |
| 4 | Microparticles and a P-selectin-mediated pathway of blood coagulation显示文摘 | Celi A Lorenzet R Furie B C | 2004 | Dis Markers2004，20，6： | 1 |
| 5 | Monoclonal antibodies to leukocyte in-tergrins CD11a/CD18 and CD11b/CD18 or inter cellular adhesion molecule-1inhibit chemoattractant-stimulated neutrophil transendothelial migration invitro显示文摘 | Tancinco M Smith C W | 1991 | Blood1991，78，20： | 1 |
| 6 | Concept for processing of silicon check valves by proton beam micromachining显示文摘 | Ducso C Rajta I Furies P | 2007 | Nuclear Instruments Methods Phys Res B2007，260，： | 1 |
| 7 | Raman Study of TiO2Role in SiO2-Al2O3-MgO-TiO2-ZnO Glass Crystallization显示文摘 | Kreimir Furi c' Leszek Stoch Jan Dutkiewicz | 2005 | Spectrochimica Acta Part A2005，61，： | 1 |
| 8 | Invited article:searching for oracles?Blood biomarkers in acute stroke显示文摘 | Foerch C Montaner J Furie KL | 2009 | Neurology2009，73，5： | 1 |
| 9 | Role of platelet P-selectin and microparticle PSGL-1 in thrombus formation显示文摘 | Bruce Furie Barbara C Furie | 2004 | Trends in Molecular Medicinec2004，10，4： | 1 |
| 10 | Thrombus formation in vivo显示文摘 | Furie B Furie B C | 2005 | J Clin Invest2005，115，12： | 1 |
| 11 | PADGEM (GMP140) is a component of Weibel-Palade bodies of human endothelial cells 显示文摘 | Bonfanti R Furie B C Furie B | 1989 | Blood1989，73，5： | 1 |
| 12 | Optimizing Ni-trogen Management in Food and Energy Production and Environmen-tal Protection:Summary Statement from the Second International Ni-trogen Conference 显示文摘 | COWLING E GALLOWAY J FURINESS C | 2001 | The Scientific World2001，1，2： | 1 |
| 13 | Surreptitious ingestion of a long-acting vitamin K antagonist/rodenticide, brodifacoum: clinical and metabolic studies of three cases 显示文摘 | Weitzel J N Sadowski J A Furie B C | 1990 | Blood1990，76，12： | 1 |
| 14 | Post-tungsten CMP cleaning:Issues and solutions显示文摘 | Myers T L Fury M A Krusell W C | 1995 | Solid State Technol1995，38，6： | 1 |
| 15 | Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adherent platelets显示文摘 | PALABRICA T LOBB R FURIE B C | 1992 | Nature1992，359，6398： | 1 |
| 16 | Surreptitious ingestion of a long-acting vitamin K antagonist/rodenticide, brodifacoum: clinical and meta-bolic studies of three cases显示文摘 | WEITZEL J N SADOWSKI J A FURIE B C | 1990 | Blood1990，76，： | 1 |
| 17 | Leukocyte ac- cumulation promoting fibrin deposition is mediated in vivo by selection on adherent platelets 显示文摘 | PALABRICA T LOBB R FURIE B C | 1992 | Nature1992，12，： | 1 |
| 18 | , role of P-setectin and the P selectin ligand, PSGL-1显示文摘 | Furie B Furie B C The molelcular basis of platelet and endothelial cell interaction with neutrophils and monocytes | 1995 | Thromb Haemost1995，74，1： | 1 |
| 19 | Surrepti- tious ingestion of a long-acting vitamin K antagonist/ro- denticide, brodifacoum: clinical and metabolic studies of three cases显示文摘 | Weitzel J N Sadowski J A Furie B C | 1990 | Blood1990，76，12： | 1 |
| 20 | Thrombus imaging in a primate model with antibodies specific for an external membrane protein of activated platelets显示文摘 | Palabrica Theresa M Furie Barbara C Konstam Marvin A | 1989 | Proc Natl Acad Sci U S A1989，86，3： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员